Valneva SE (VALN)
USD 3.71
(0.59%)
USD 3.71
(0.59%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 208.81 Million EUR | 37.04% |
| 2022 | 152.38 Million EUR | 32.9% |
| 2021 | 114.65 Million EUR | 8.73% |
| 2020 | 105.45 Million EUR | 23.75% |
| 2019 | 85.21 Million EUR | 47.94% |
| 2018 | 57.6 Million EUR | -19.43% |
| 2017 | 71.49 Million EUR | -13.34% |
| 2016 | 82.5 Million EUR | -19.32% |
| 2015 | 102.25 Million EUR | 39.78% |
| 2014 | 73.15 Million EUR | 2.63% |
| 2013 | 71.28 Million EUR | 961.69% |
| 2012 | 6.71 Million EUR | -1.21% |
| 2011 | 6.79 Million EUR | -0.03% |
| 2010 | 6.79 Million EUR | 6.47% |
| 2009 | 6.38 Million EUR | 37.85% |
| 2008 | 4.63 Million EUR | 25.53% |
| 2007 | 3.69 Million EUR | 10.58% |
| 2006 | 3.33 Million EUR | 9.02% |
| 2005 | 3.06 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 209.63 Million EUR | -0.96% |
| 2024 Q1 | 211.67 Million EUR | 1.37% |
| 2023 Q4 | 208.81 Million EUR | 7.36% |
| 2023 Q1 | 152.72 Million USD | 0.23% |
| 2023 FY | 208.81 Million EUR | 37.04% |
| 2023 Q2 | 149.23 Million EUR | -2.29% |
| 2023 Q3 | 194.5 Million EUR | 30.34% |
| 2022 Q2 | 133.52 Million EUR | 15.58% |
| 2022 Q3 | 161.61 Million EUR | 21.04% |
| 2022 Q4 | 152.38 Million EUR | -5.72% |
| 2022 FY | 152.38 Million EUR | 32.9% |
| 2022 Q1 | 115.52 Million EUR | 0.75% |
| 2021 Q4 | 114.65 Million EUR | 0.0% |
| 2021 FY | 114.65 Million EUR | 8.73% |
| 2021 Q2 | 111.48 Million EUR | 5.17% |
| 2021 Q1 | 106 Million EUR | 0.53% |
| 2020 Q4 | 105.45 Million EUR | -5.23% |
| 2020 FY | 105.45 Million EUR | 23.75% |
| 2020 Q1 | 99.28 Million EUR | 16.51% |
| 2020 Q2 | 112.95 Million EUR | 13.76% |
| 2020 Q3 | 111.26 Million EUR | -1.49% |
| 2019 Q2 | 73.71 Million EUR | -3.64% |
| 2019 FY | 85.21 Million EUR | 47.94% |
| 2019 Q1 | 76.49 Million EUR | 32.81% |
| 2019 Q4 | 85.21 Million EUR | 1.66% |
| 2019 Q3 | 83.82 Million EUR | 13.7% |
| 2018 Q4 | 57.6 Million EUR | -4.55% |
| 2018 Q3 | 60.34 Million EUR | -2.65% |
| 2018 Q2 | 61.98 Million EUR | -6.81% |
| 2018 Q1 | 66.51 Million EUR | -6.97% |
| 2018 FY | 57.6 Million EUR | -19.43% |
| 2017 Q3 | 69.91 Million EUR | -5.62% |
| 2017 Q4 | 71.49 Million EUR | 2.27% |
| 2017 FY | 71.49 Million EUR | -13.34% |
| 2017 Q2 | 74.07 Million EUR | -1.69% |
| 2017 Q1 | 75.34 Million EUR | -8.67% |
| 2016 Q2 | 80.46 Million EUR | -2.38% |
| 2016 FY | 82.5 Million EUR | -19.32% |
| 2016 Q4 | 82.5 Million EUR | 2.87% |
| 2016 Q3 | 80.2 Million EUR | -0.33% |
| 2016 Q1 | 82.42 Million EUR | -19.39% |
| 2015 Q2 | 89.25 Million EUR | -1.75% |
| 2015 FY | 102.25 Million EUR | 39.78% |
| 2015 Q3 | 87.99 Million EUR | -1.41% |
| 2015 Q4 | 102.25 Million EUR | 16.21% |
| 2015 Q1 | 90.84 Million EUR | 24.18% |
| 2014 Q2 | 70.59 Million EUR | -1.03% |
| 2014 FY | 73.15 Million EUR | 2.63% |
| 2014 Q4 | 73.15 Million EUR | 2.24% |
| 2014 Q3 | 71.55 Million EUR | 1.36% |
| 2014 Q1 | 71.32 Million EUR | 0.06% |
| 2013 Q1 | - EUR | -100.0% |
| 2013 Q2 | 79.39 Million EUR | 0.0% |
| 2013 Q3 | 51.59 Million EUR | -35.02% |
| 2013 Q4 | 71.28 Million EUR | 38.16% |
| 2013 FY | 71.28 Million EUR | 961.69% |
| 2012 Q2 | 6.21 Million EUR | 0.0% |
| 2012 Q4 | 6.71 Million EUR | 0.0% |
| 2012 FY | 6.71 Million EUR | -1.21% |
| 2011 Q4 | 6.79 Million EUR | 0.0% |
| 2011 Q2 | 7.61 Million EUR | 0.0% |
| 2011 FY | 6.79 Million EUR | -0.03% |
| 2010 Q2 | 6.94 Million EUR | 0.0% |
| 2010 Q4 | 6.79 Million EUR | 0.0% |
| 2010 FY | 6.79 Million EUR | 6.47% |
| 2009 FY | 6.38 Million EUR | 37.85% |
| 2009 Q4 | 6.38 Million EUR | 0.0% |
| 2008 FY | 4.63 Million EUR | 25.53% |
| 2007 FY | 3.69 Million EUR | 10.58% |
| 2006 FY | 3.33 Million EUR | 9.02% |
| 2005 FY | 3.06 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 8.986% |
| IO Biotech, Inc. | 2.49 Million USD | -8272.735% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -97477.57% |
| Organovo Holdings, Inc. | 1.39 Million USD | -14879.627% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -427188.725% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -127252.455% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -2027.953% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -2872.893% |
| Savara Inc. | 26.73 Million USD | -680.971% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -30835.704% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -733.863% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -899.874% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2412284.473% |
| Soligenix, Inc. | 3.49 Million USD | -5875.457% |
| Aptose Biosciences Inc. | 1 Million USD | -20578.823% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -948.22% |
| Century Therapeutics, Inc. | 48.17 Million USD | -333.489% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -399.046% |
| Precision BioSciences, Inc. | 31.26 Million USD | -567.827% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -12.043% |
| Kura Oncology, Inc. | 17.2 Million USD | -1114.047% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Dyadic International, Inc. | 136.92 Thousand USD | -152399.471% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -125.911% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -7170.752% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1394.318% |
| Autolus Therapeutics plc | 52.96 Million USD | -294.238% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3727.974% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3718.175% |
| GRI Bio, Inc. | 14 Thousand USD | -1491442.857% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1580.747% |
| IGM Biosciences, Inc. | 40.5 Million USD | -415.519% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -16.249% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3435.025% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -25154.582% |
| Opthea Limited | 200.62 Million USD | -4.081% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -258.292% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -260.824% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1736.229% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3287.121% |
| Surrozen, Inc. | 3.37 Million USD | -6079.817% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 3.13 Million USD | -6560.587% |
| Ovid Therapeutics Inc. | 46 Million USD | -353.931% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -55.249% |
| Acelyrin, Inc. | 1.19 Million USD | -17388.777% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -146.862% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -99802.402% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -591.078% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -236.393% |
| ADMA Biologics, Inc. | 141.41 Million USD | -47.659% |
| PureTech Health plc | 25.51 Million USD | -718.501% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -65565.409% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -11852.833% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1509.248% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -146.612% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -84440.891% |
| ChromaDex Corporation | 3.27 Million USD | -6272.17% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -33471.542% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -9.936% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -100.434% |
| Better Therapeutics, Inc. | 14.88 Million USD | -1303.333% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -582.093% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -88.245% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -448.016% |
| Seer, Inc. | 28.25 Million USD | -638.936% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -3306.46% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -3207.714% |
| Gritstone bio, Inc. | 104.77 Million USD | -99.299% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7395.19% |
| Avid Bioservices, Inc. | 207.83 Million USD | -0.472% |
| Insmed Incorporated | 1.2 Billion USD | 82.656% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -3920.331% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -5250.141% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -101.684% |
| MediWound Ltd. | 6.71 Million USD | -3011.548% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -105.965% |
| Fortress Biotech, Inc. | 88.59 Million USD | -135.705% |
| OmniAb, Inc. | 25.56 Million USD | -716.932% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 2.393% |
| Zai Lab Limited | 15.15 Million USD | -1278.232% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 56.354% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -558.061% |
| Veracyte, Inc. | 12.63 Million USD | -1553.333% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3766.963% |
| FibroGen, Inc. | 170.45 Million USD | -22.505% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -10166.278% |
| ContextLogic Inc. | 6 Million USD | -3380.267% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -132062.025% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -3083.656% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.398% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -206.047% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -564267.568% |
| ImmuCell Corporation | 11.96 Million USD | -1644.596% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 87.556% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2753.847% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7395.19% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -363.284% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -383.717% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -361.615% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -332.968% |
| Vaxxinity, Inc. | 15.16 Million USD | -1276.688% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 75.396% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -20224.743% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1471056.827% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -883.172% |
| Senti Biosciences, Inc. | 37.66 Million USD | -454.389% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -128547.03% |
| Apollomics, Inc. | 4.66 Million USD | -4380.069% |
| 89bio, Inc. | 27.1 Million USD | -670.311% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -81.31% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -46244.749% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -2923.69% |
| Ardelyx, Inc. | 55.98 Million USD | -273.006% |
| Pluri Inc. | 29.61 Million USD | -605.174% |
| Prothena Corporation plc | 11.83 Million USD | -1664.394% |
| Pulmatrix, Inc. | 8.75 Million USD | -2284.833% |
| Celularity Inc. | 65.41 Million USD | -219.208% |
| MeiraGTx Holdings plc | 89.26 Million USD | -133.931% |
| Omeros Corporation | 338.28 Million USD | 38.271% |
| Ainos, Inc. | 5.96 Million USD | -3401.535% |
| Humacyte, Inc. | 58.1 Million USD | -259.371% |
| Mesoblast Limited | 118.92 Million USD | -75.589% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -11169.077% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -4181.649% |
| Blueprint Medicines Corporation | 774.12 Million USD | 73.025% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -4061.339% |
| Summit Therapeutics Inc. | 106.09 Million USD | -96.812% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -237.792% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -81.034% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -561.899% |
| Cytokinetics, Incorporated | 755.77 Million USD | 72.37% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -1460.191% |
| Nutriband Inc. | 241.28 Thousand USD | -86443.299% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3719.572% |
| Roivant Sciences Ltd. | 499.74 Million USD | 58.216% |
| Evogene Ltd. | 1.13 Million USD | -18249.385% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -16932.3% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -378429.865% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 87.998% |
| BioLineRx Ltd. | 11.59 Million USD | -1701.536% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1167.395% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -9749.811% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -113.935% |
| MediciNova, Inc. | 215.92 Thousand USD | -96607.205% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -8269.379% |
| MiMedx Group, Inc. | 48.09 Million USD | -334.138% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 49.686% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -5716.602% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -12671.621% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -255551.322% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2179.402% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1323.325% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -661.685% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1603.508% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1569.727% |
| Allakos Inc. | 41.46 Million USD | -403.596% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1829.729% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -138188.742% |
| BioAtla, Inc. | 2.46 Million USD | -8388.455% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -119.527% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -3665.164% |
| Precigen, Inc. | 7.09 Million USD | -2842.314% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| XOMA Corporation | 124.45 Million USD | -67.791% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1002.921% |
| Incyte Corporation | 38.28 Million USD | -445.397% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -383.74% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1774.807% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 12.495% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -701.812% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -59732.665% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -63857.267% |
| UroGen Pharma Ltd. | 100.21 Million USD | -108.37% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -14.264% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -60191.85% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -68364.262% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -2955.099% |
| Chimerix, Inc. | 2.14 Million USD | -9639.552% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -487.3% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -120831.472% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -687.599% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -444189.362% |
| OncoCyte Corporation | 2.86 Million USD | -7178.355% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -15972.462% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -977960.89% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -138598.407% |
| Purple Biotech Ltd. | 351 Thousand USD | -59391.738% |
| NextCure, Inc. | 6.6 Million USD | -3061.484% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -113.308% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -3891.894% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 8.89% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -21471.901% |
| NLS Pharmaceutics AG | 1.63 Million USD | -12681.424% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | 25.592% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Curis, Inc. | 2.79 Million USD | -7373.729% |
| Daré Bioscience, Inc. | 5.31 Million USD | -3826.482% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -36858.584% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -364.49% |
| BeiGene, Ltd. | 930.18 Million USD | 77.551% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -1243.516% |
| Alector, Inc. | 38.91 Million USD | -436.554% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -18201.139% |
| Erasca, Inc. | 55.85 Million USD | -273.827% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -967.73% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -717.092% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -53169.116% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 81.584% |
| Histogen Inc. | 4.62 Million USD | -4417.871% |
| Fortress Biotech, Inc. | 88.59 Million USD | -135.705% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -2019.529% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -230.578% |
| Galecto, Inc. | 249 Thousand USD | -83761.847% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 67.619% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -50.195% |
| Molecular Templates, Inc. | 12.23 Million USD | -1607.408% |
| PDS Biotechnology Corporation | 23.85 Million USD | -775.479% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -4828.393% |
| Amarin Corporation plc | 8.73 Million USD | -2290.019% |
| TG Therapeutics, Inc. | 110.79 Million USD | -88.471% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3769.112% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -8114.634% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1007.601% |
| Onconetix, Inc. | 9.88 Million USD | -2012.288% |
| MacroGenics, Inc. | 33.97 Million USD | -514.689% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -14615.715% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Adagene Inc. | 22.3 Million USD | -836.106% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 0.631% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1806.125% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -929.005% |
| SciSparc Ltd. | 76 Thousand USD | -274657.895% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -154.601% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -63369.909% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -725.425% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -1.408% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -290.558% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 92.216% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2626.984% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -331353.968% |
| 2seventy bio, Inc. | 256.67 Million USD | 18.645% |
| Clene Inc. | 32.16 Million USD | -549.283% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -9413.257% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -102305.461% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2294.404% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Absci Corporation | 15.95 Million USD | -1208.617% |
| XBiotech Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1114.258% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -676.816% |
| Entera Bio Ltd. | 390 Thousand USD | -53442.564% |
| Trevena, Inc. | 35.23 Million USD | -492.672% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -727.486% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -659.745% |
| INmune Bio, Inc. | 10.43 Million USD | -1900.728% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -43290.788% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -3114.532% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -509207.317% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -673.679% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -41587.912% |
| Jaguar Health, Inc. | 35.86 Million USD | -482.309% |
| Clearside Biomedical, Inc. | 43 Million USD | -385.607% |
| NexImmune, Inc. | 68.8 Thousand USD | -303371.93% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -44806.667% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -16956.981% |
| Kronos Bio, Inc. | 28.27 Million USD | -638.596% |
| Innoviva, Inc. | 449.07 Million USD | 53.501% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 56.573% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 92.274% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -932.771% |
| Verastem, Inc. | 41.55 Million USD | -402.481% |
| ProKidney Corp. | 4.41 Million USD | -4631.838% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -13328.682% |
| Imunon, Inc. | 1.62 Million USD | -12752.477% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -16472.698% |
| Statera Biopharma, Inc. | 16.26 Million USD | -1184.141% |
| ImmunityBio, Inc. | 883.67 Million USD | 76.37% |
| Korro Bio, Inc. | 33.2 Million USD | -528.831% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 48.413% |
| Kineta, Inc. | 1.31 Million USD | -15755.429% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -5770.565% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3620.782% |
| GT Biopharma, Inc. | 58 Thousand USD | -359927.586% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1345.694% |
| Celularity Inc. | 65.41 Million USD | -219.208% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -303.681% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cibus, Inc. | 24.62 Million USD | -748.122% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -194.206% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -89.217% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -54421.149% |
| Kodiak Sciences Inc. | 181.63 Million USD | -14.967% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -100.599% |
| Annexon, Inc. | 31.35 Million USD | -565.974% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -178.288% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -8816.14% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -2918.881% |
| Moderna, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1407.697% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 85.634% |
| Vor Biopharma Inc. | 35.66 Million USD | -485.575% |
| Eyenovia, Inc. | 16.1 Million USD | -1196.369% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -52104.0% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -87.296% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -353.563% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -550.153% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -21099.594% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -265.031% |
| Immunocore Holdings plc | 84.03 Million USD | -148.496% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -436.526% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -190.802% |
| Alkermes plc | 290.73 Million USD | 28.175% |
| Arcellx, Inc. | 97.62 Million USD | -113.896% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -8419.639% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -356.199% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -321155.385% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -6631.657% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -16459.188% |
| Moolec Science SA | 2.64 Million USD | -7793.882% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1928.127% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Geron Corporation | 85.89 Million USD | -143.095% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3408.333% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -358.835% |
| Royalty Pharma plc | 6.13 Billion USD | 96.596% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -8593.422% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -12433.974% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -181078.961% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -517.251% |
| Humacyte, Inc. | 58.1 Million USD | -259.371% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3729.378% |
| NLS Pharmaceutics AG | 1.63 Million USD | -12681.424% |
| Genelux Corporation | 2.51 Million USD | -8189.639% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -259854.188% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1283.345% |
| Notable Labs, Ltd. | 2.04 Million USD | -10091.118% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -69340.066% |
| Mustang Bio, Inc. | 2.49 Million USD | -8259.327% |
| Immunovant, Inc. | 138 Thousand USD | -151215.942% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -12697.254% |
| Vericel Corporation | 88.14 Million USD | -136.906% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 86.072% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 29.22 Million USD | -614.536% |
| Orgenesis Inc. | 22.62 Million USD | -823.107% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -4430.614% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -102765.025% |
| GH Research PLC | 343 Thousand USD | -60779.3% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -910.677% |
| PepGen Inc. | 20.1 Million USD | -938.679% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -36279.094% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -206648.515% |
| Belite Bio, Inc | 886 Thousand USD | -23468.397% |
| Pharming Group N.V. | 171.54 Million USD | -21.727% |
| XOMA Corporation | 124.45 Million USD | -67.791% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -21361.048% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 12.855% |
| Xencor, Inc. | 83.43 Million USD | -150.277% |
| Replimune Group, Inc. | 75.86 Million USD | -175.232% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -878.932% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2120.502% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Turnstone Biologics Corp. | 3.21 Million USD | -6397.075% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1140.737% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -8539.47% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -16459.188% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -184692.92% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -20134.109% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -6510.193% |
| scPharmaceuticals Inc. | 40.26 Million USD | -418.553% |
| HilleVax, Inc. | 51.19 Million USD | -307.9% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -288.799% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2199.482% |
| Immunic, Inc. | 1.33 Million USD | -15553.373% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Aptorum Group Limited | 3.36 Million USD | -6110.331% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -51715.385% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2199.482% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -9673.975% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1148.078% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -9612.372% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 53.081% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -71994.268% |
| bluebird bio, Inc. | 330.32 Million USD | 36.785% |
| DBV Technologies S.A. | 14.38 Million USD | -1352.027% |
| Compugen Ltd. | 1.35 Million USD | -15356.403% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Peak Bio, Inc. | 10.72 Million USD | -1847.582% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -8245.963% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3263.66% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -12277.949% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -388.276% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -4396.469% |
| Benitec Biopharma Inc. | 284 Thousand USD | -73426.761% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -146.959% |
| Adicet Bio, Inc. | 20.92 Million USD | -897.974% |
| Prime Medicine, Inc. | 13.63 Million USD | -1431.695% |
| Aditxt, Inc. | 18.21 Million USD | -1046.208% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -78.181% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1264.543% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -25730.713% |
| PolyPid Ltd. | 11.77 Million USD | -1672.782% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -128.319% |
| Invivyd, Inc. | 2.16 Million USD | -9545.081% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -5925893.195% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -244.7% |
| CorMedix Inc. | 667.63 Thousand USD | -31177.111% |
| Instil Bio, Inc. | 86.05 Million USD | -142.657% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -312.093% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -8.087% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -593.142% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -3667.202% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1472.883% |
| AbCellera Biologics Inc. | 77.38 Million USD | -169.858% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -150.412% |
| Surrozen, Inc. | 3.37 Million USD | -6079.817% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -750.852% |
| Verona Pharma plc | 51.32 Million USD | -306.819% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -34529.519% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -67.67% |
| Evaxion Biotech A/S | 10.86 Million USD | -1821.087% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -178.767% |
| Shattuck Labs, Inc. | 4.2 Million USD | -4869.443% |
| AlloVir, Inc. | 27.42 Million USD | -661.296% |
| BioVie Inc. | 6.11 Million USD | -3316.801% |
| Codexis, Inc. | 22.36 Million USD | -833.715% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -22948.124% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -127252.455% |
| Agenus Inc. | 350.24 Million USD | 40.38% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -92996.745% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -88958.348% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -892.094% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -973.88% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Celcuity Inc. | 37.44 Million USD | -457.641% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -9616.892% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -633.022% |
| IN8bio, Inc. | 4.89 Million USD | -4167.648% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -15506.577% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -96.877% |
| Liquidia Corporation | 3.5 Million USD | -5861.062% |
| Quantum-Si incorporated | 15.3 Million USD | -1264.543% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -255551.322% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1815.216% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -12532.547% |
| United Therapeutics Corporation | 700 Million USD | 70.169% |
| Solid Biosciences Inc. | 26.26 Million USD | -695.035% |
| Immuneering Corporation | 4.46 Million USD | -4578.869% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1472.883% |
| uniQure N.V. | 138.4 Million USD | -50.869% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1722.606% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -144.449% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -43861.263% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1471.7% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -99105.184% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1321.0% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -76110.219% |
| Zura Bio Limited | - USD | -Infinity% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -592.889% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -21099.594% |
| Immunome, Inc. | 1.65 Million USD | -12555.515% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -11949.394% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -2035.57% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -591.232% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -57583.978% |
| Altimmune, Inc. | 671 Thousand USD | -31020.119% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -303.314% |
| Rallybio Corporation | 392 Thousand USD | -53169.388% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -4894.403% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -35595.043% |
| Moolec Science SA | 2.64 Million USD | -7793.882% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -50217.108% |
| NeurAxis, Inc. | 224.26 Thousand USD | -93013.351% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 65.822% |
| Lumos Pharma, Inc. | 6.58 Million USD | -3071.086% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -2035.57% |
| 180 Life Sciences Corp. | 1.32 Million USD | -15718.567% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -948.22% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1122.567% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -13328.682% |
| Nutriband Inc. | 241.28 Thousand USD | -86443.299% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -25180.387% |
| argenx SE | 20 Million USD | -944.08% |
| Neurogene Inc. | 16.25 Million USD | -1184.626% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 32.234% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -631.635% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| AnaptysBio, Inc. | 17.81 Million USD | -1072.202% |
| Design Therapeutics, Inc. | 3.05 Million USD | -6746.426% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -79600.763% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1367.641% |
| Achilles Therapeutics plc | 4.61 Million USD | -4424.724% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -146953.521% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1944.61% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 44.125% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -593.764% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -5546.933% |
| Palisade Bio, Inc. | 369 Thousand USD | -56489.702% |
| Beam Therapeutics Inc. | 173.17 Million USD | -20.582% |
| AEON Biopharma, Inc. | 278 Thousand USD | -75013.669% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -62233.134% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -195254.146% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -175.258% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -241.722% |
| Athira Pharma, Inc. | 1.58 Million USD | -13074.511% |
| Vaccinex, Inc. | 247 Thousand USD | -84440.891% |
| HCW Biologics Inc. | 6.45 Million USD | -3136.566% |
| XOMA Corporation | 124.45 Million USD | -67.791% |
| Nektar Therapeutics | 230.4 Million USD | 9.368% |
| Arvinas, Inc. | 3.4 Million USD | -6041.647% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -12697.254% |
| Merus N.V. | 12.16 Million USD | -1616.954% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -62.594% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1411.626% |
| Rezolute, Inc. | 2.22 Million USD | -9272.352% |
| Clene Inc. | 32.16 Million USD | -549.283% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -119187.302% |
| BeyondSpring Inc. | 3.99 Million USD | -5126.934% |
| Synlogic, Inc. | 17.27 Million USD | -1108.776% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -15962.769% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -596517.143% |
| Peak Bio, Inc. | 10.72 Million USD | -1847.582% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -302.165% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2479.887% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -17.964% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -2858.991% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -152773.479% |
| MannKind Corporation | 382.37 Million USD | 45.39% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1844.645% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -50955.257% |
| Gossamer Bio, Inc. | 212.46 Million USD | 1.717% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -119909.195% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2179.402% |
| Legend Biotech Corporation | 328.67 Million USD | 36.467% |
| Mural Oncology plc | 15 Million USD | -1291.272% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -340.299% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -9838.886% |
| Champions Oncology, Inc. | 7.43 Million USD | -2710.444% |
| REGENXBIO Inc. | 89.29 Million USD | -133.863% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -24331.582% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -37661.808% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3756.963% |
| Vaxart, Inc. | 26.51 Million USD | -687.569% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1233.66% |
| Cellectis S.A. | 92.85 Million USD | -124.889% |
| Longeveron Inc. | 2.04 Million USD | -10131.063% |
| Repare Therapeutics Inc. | 3.41 Million USD | -6023.636% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 85.05% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -348.18% |
| Revolution Medicines, Inc. | 87.94 Million USD | -137.442% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -120602.89% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -5182.469% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -65772.555% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -119223.429% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 74.169% |
| Denali Therapeutics Inc. | 52.24 Million USD | -299.717% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1349.561% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -15097.671% |
| Cingulate Inc. | 3.13 Million USD | -6560.587% |
| Passage Bio, Inc. | 26.29 Million USD | -694.158% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -3033.023% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -51080.392% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -23257.494% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -137.442% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -915.593% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -16472.698% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -8419.204% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -6586.391% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -25647.965% |
| OmniAb, Inc. | 25.56 Million USD | -716.932% |
| Anew Medical, Inc. | 1.6 Million USD | -12910.343% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -605.868% |
| Lipocine Inc. | 17.16 Thousand USD | -1216351.124% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1694.26% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -503.026% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3435.025% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -265.235% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -102765.025% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -3942.904% |
| Ocugen, Inc. | 6.94 Million USD | -2908.443% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1377.925% |
| Q32 Bio Inc. | 1.31 Million USD | -15743.399% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -30973.81% |
| Alumis Inc. Common Stock | 32.58 Million USD | -540.933% |
| Equillium, Inc. | 824 Thousand USD | -25241.748% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2199.989% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -69318.828% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -37.109% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -308.338% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -26842.331% |
| Dominari Holdings Inc. | 3.02 Million USD | -6796.169% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -220899.714% |
| vTv Therapeutics Inc. | 529 Thousand USD | -39373.724% |
| Bio-Techne Corporation | 419.53 Million USD | 50.227% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -190.038% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -7.878% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1136.476% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -817.389% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3346.946% |
| Nkarta, Inc. | 88.33 Million USD | -136.38% |
| BioCardia, Inc. | 1.31 Million USD | -15779.544% |
| Iterum Therapeutics plc | 19.5 Million USD | -970.357% |